Kolmar Korea in tie-up with Pharmascience

Published: 2013-01-03 06:57:00

Updated: 2013-01-03 06:57:00

Kolmar Korea, one of the nation’s innovative pharmaceutical firms, said Saturday it has signed an agreement with Pharmascience Inc. to establish Pharmascience Korea, a joint venture firm here in 2014.

Pharmascience Korea will be 50 percent owned by each side, according to Kolmar Korea.

Comm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK